Profile data is unavailable for this security.
About the company
JD Health International Inc is an investment holding company primarily engaged in the provision of pharmaceutical and healthcare products, internet healthcare, health management and intelligent healthcare solutions. The Company's businesses primarily include retail pharmacy and healthcare services. The retail pharmacy business is primarily engaged in the sales of pharmaceuticals and health products, as well as medical devices through online marketplace and on-demand retail channels. The healthcare services business is primarily engaged in the provision of healthcare services through Internet hospitals and large language models. The Company is also engaged in the provision of online marketing services such as advertising. The Company primarily conducts its businesses in the domestic market.
- Revenue in HKD (TTM)73.66bn
- Net income in HKD5.34bn
- Incorporated2018
- Employees4.57k
- LocationJD Health International Inc8th Floor, Building C No. 18 Kechuang 11, Yizhuang Economic and TechnologicalDevelopment Zone, Daxing DistrictBEIJING 101111ChinaCHN
- Websitehttps://ir.jdhealth.com/
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 93.12m | 2.90% |
| Krane Funds Advisors LLCas of 05 Feb 2026 | 50.16m | 1.56% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 40.17m | 1.25% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 35.38m | 1.10% |
| CSOP Asset Management Ltd.as of 05 Feb 2026 | 25.11m | 0.78% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 22.93m | 0.71% |
| Hang Seng Investment Management Ltd.as of 06 Feb 2026 | 16.14m | 0.50% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 15.80m | 0.49% |
| BlackRock Advisors (UK) Ltd.as of 06 Feb 2026 | 12.75m | 0.40% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 11.07m | 0.35% |
